Skip to content

National retrospective multicenter study on inhaled nitric oxide in preterm infants requiring respiratory support

National retrospective multicenter study on inhaled nitric oxide in preterm infants requiring respiratory support

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066935
Enrollment
Unknown
Registered
2022-12-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory failure of premature infants

Interventions

inhaled nitric oxide:N/A

Sponsors

Xiamen Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? The gestational age at birth was 22-37 weeks; ? Receive invasive or non-invasive respiratory support; ? Receive iNO treatment and maintain it for more than 3 hours.

Exclusion criteria

Exclusion criteria: ? Congenital malformation or genetic metabolic disease; ? Complex congenital heart disease (except atrial septal defect or ventricular septal defect) ? NO was applied after various surgical treatments in neonatal period;

Design outcomes

Primary

MeasureTime frame
iNO usage rate;Treatment outcome;

Secondary

MeasureTime frame
Disease spectrum of premature infants using iNO;Positive rate of iNO treatment;Direct causes of NO use in premature infants;Before and 3 ± 1h, 24 ± 6h, 48 ± 6h, 72 ± 6h after the treatment of iNO (recorded at 24h intervals until NO evacuation), blood gas indicators (pH, PaO2, PaCO2, SBE), SPO2 before and after the catheter and difference, oxygenation index (OI), P/F (PaO2/FiO2) values;Ventilator parameters (FiO2, MAP, Pose, RR) before and 3 ± 1h, 24 ± 6h, 48 ± 6h, 72 ± 6h after treatment with iNO (recorded at 24h intervals until NO evacuation);INO treatment start time (d+h), initial dose (ppm), maximum dose (ppm), maintenance time (d+h);Pulmonary artery pressure measured by cardiac ultrasound before iNO treatment or 24h, 48h and 72h after treatment;General situation;Maternal diseases;Auxiliary ventilation mode and time;medication;Monitoring of platelet count and coagulation function after iNO;Impact of complications;Hospitalization days;

Countries

China

Contacts

Public ContactLin xinzhu

Xiamen Maternal and Child Health Care Hospital

xinzhufj@163.com13328312516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026